Hsu‐Shan Huang

2.8k total citations
126 papers, 2.4k citations indexed

About

Hsu‐Shan Huang is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Hsu‐Shan Huang has authored 126 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 31 papers in Organic Chemistry and 29 papers in Toxicology. Recurrent topics in Hsu‐Shan Huang's work include Bioactive Compounds and Antitumor Agents (29 papers), Cancer therapeutics and mechanisms (24 papers) and Synthesis and biological activity (20 papers). Hsu‐Shan Huang is often cited by papers focused on Bioactive Compounds and Antitumor Agents (29 papers), Cancer therapeutics and mechanisms (24 papers) and Synthesis and biological activity (20 papers). Hsu‐Shan Huang collaborates with scholars based in Taiwan, United States and Japan. Hsu‐Shan Huang's co-authors include J. David Van Horn, Tsung‐Chih Chen, Chia-Chung Lee, Chun‐Liang Chen, Jing‐Jer Lin, Alexander T.H. Wu, Kuo-Feng Huang, Deh‐Ming Chang, Hui‐Fen Chiu and Ahmed Ali and has published in prestigious journals such as PLoS ONE, Scientific Reports and Coordination Chemistry Reviews.

In The Last Decade

Hsu‐Shan Huang

123 papers receiving 2.4k citations

Peers

Hsu‐Shan Huang
Jorge A. R. Salvador Portugal
Rajeshwar P. Verma United States
Qiuzhi Cindy Cui United States
Marinella Roberti Italy
Dayong Shi China
Hongtao Xu China
Peter L. Gutiérrez United States
Woo Hyun Park South Korea
Zhiguo Liu China
Lisa K. Folkes United Kingdom
Jorge A. R. Salvador Portugal
Hsu‐Shan Huang
Citations per year, relative to Hsu‐Shan Huang Hsu‐Shan Huang (= 1×) peers Jorge A. R. Salvador

Countries citing papers authored by Hsu‐Shan Huang

Since Specialization
Citations

This map shows the geographic impact of Hsu‐Shan Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsu‐Shan Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsu‐Shan Huang more than expected).

Fields of papers citing papers by Hsu‐Shan Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsu‐Shan Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsu‐Shan Huang. The network helps show where Hsu‐Shan Huang may publish in the future.

Co-authorship network of co-authors of Hsu‐Shan Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Hsu‐Shan Huang. A scholar is included among the top collaborators of Hsu‐Shan Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsu‐Shan Huang. Hsu‐Shan Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuo, Yu-Cheng, Bashir Lawal, Adewale Oluwaseun Fadaka, et al.. (2024). Evaluation of terpenes rich Hura crepitans extract on glucose regulation and diabetic complications in STZ-induced diabetic rats. Biomedicine & Pharmacotherapy. 179. 117308–117308. 3 indexed citations
2.
Angom, Ramcharan Singh, Jian Zhu, Alexander T.H. Wu, et al.. (2021). LCC-09, a Novel Salicylanilide Derivative, Exerts Anti-Inflammatory Effect in Vascular Endothelial Cells. Journal of Inflammation Research. Volume 14. 4551–4565. 3 indexed citations
3.
4.
Huang, Hsu‐Shan, et al.. (2020). TDAG8 deficiency reduces satellite glial number and pro-inflammatory macrophage number to relieve rheumatoid arthritis disease severity and chronic pain. Journal of Neuroinflammation. 17(1). 170–170. 25 indexed citations
5.
Chiang, Hao, et al.. (2020). Temporal expression patterns of distinct cytokines and M1/M2 macrophage polarization regulate rheumatoid arthritis progression. Molecular Biology Reports. 47(5). 3423–3437. 36 indexed citations
6.
Hsieh, Chia‐Ling, et al.. (2019). A Novel Salicylanilide Derivative Induces Autophagy Cell Death in Castration-Resistant Prostate Cancer via ER Stress-Activated PERK Signaling Pathway. Molecular Cancer Therapeutics. 19(1). 101–111. 24 indexed citations
7.
Madamsetty, Vijay Sagar, Krishnendu Pal, Shamit K. Dutta, et al.. (2019). Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma. Bioconjugate Chemistry. 30(10). 2703–2713. 16 indexed citations
8.
Chuang, Show‐Mei, et al.. (2016). Selective recognition and stabilization of new ligands targeting the potassium form of the human telomeric G-quadruplex DNA. Scientific Reports. 6(1). 31019–31019. 20 indexed citations
9.
Chen, Tsung‐Chih, et al.. (2016). TC-N19, a novel dual inhibitor of EGFR and cMET, efficiently overcomes EGFR-TKI resistance in non-small-cell lung cancer cells. Cell Death and Disease. 7(6). e2290–e2290. 33 indexed citations
10.
Chen, Tsung‐Chih, Dah‐Shyong Yü, Kuo-Feng Huang, et al.. (2013). Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents. European Journal of Medicinal Chemistry. 69. 278–293. 23 indexed citations
11.
Cheng, Meng‐Hsuan, et al.. (2011). B1, a novel topoisomerase II inhibitor, induces apoptosis and cell cycle G1 arrest in lung adenocarcinoma A549 cells. Anti-Cancer Drugs. 23(2). 191–199. 15 indexed citations
12.
Chang, Ching-Chih, Hui‐Chun Huang, Yi‐Jen Chen, et al.. (2011). Investigation of Hepatoprotective Activity of Induced Pluripotent Stem Cells in the Mouse Model of Liver Injury. BioMed Research International. 2011(1). 219060–219060. 13 indexed citations
13.
Huang, Hsu‐Shan, et al.. (2007). A Concise Paradigm for the Construction of Amide Linker of 2,7-Diamidoanthraquinone Derivatives as Potential Telomerase Inhibitors. Zhōnghuá yàoxué zázhì. 59(4). 179–187. 2 indexed citations
14.
Preobrazhenskaya, M. N., et al.. (2006). Second Generation Drugs-derivatives of Natural Antitumor Anthracycline Antibiotics Daunorubicin, Doxorubicin and Carminomycin. Journal of the Medical Sciences (Berkala Ilmu Kedokteran). 26(4). 119–128. 12 indexed citations
15.
Preobrazhenskaya, M. N., Andrey E. Shchekotikhin, Аlexander А. Shtil, & Hsu‐Shan Huang. (2006). Antitumor Anthraquinone Analogues for Multidrug Resistant Tumor Cells. Journal of the Medical Sciences (Berkala Ilmu Kedokteran). 26(1). 1–4. 7 indexed citations
16.
Luo, Huiying, Hsu‐Shan Huang, Yingguo Bai, et al.. (2006). Improving Phytase Expression by Increasing the Gene Copy Number of appA-m in Pichia pastoris. Chinese journal of biotechnology/Shengwu gongcheng xuebao. 22(4). 528–533. 17 indexed citations
17.
Huang, Hsu‐Shan, et al.. (2005). Human telomerase inhibition and cytotoxicity of regioisomeric disubstituted amidoanthraquinones and aminoanthraquinones. Bioorganic & Medicinal Chemistry. 13(5). 1435–1444. 33 indexed citations
18.
Huang, Hsu‐Shan, et al.. (2001). Chromophore-Modified Antitumor Anthracenes. 1. Cytotoxic Activity of 9-Acyloxy 1,5-Dichloroanthracene Analogues. Zhōnghuá yàoxué zázhì. 53(2). 71–83. 2 indexed citations
19.
Müller, Klaus & Hsu‐Shan Huang. (1996). Development of novel antipsoriatic anthrones. Zhōnghuá yàoxué zázhì. 48(5). 337–354. 1 indexed citations
20.
Ding, Yu‐An, Benjamin N. Chiang, Mau‐Song Chang, et al.. (1995). Summary of national guidelines for diagnosis and management of lipid disorders in Taiwan. Zhōnghuá mínguó xīnzàngxué huì zázhì. 11(1). 1–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jorge A. R. Salvador Breakdown of academic impact, for papers by Rajeshwar P. Verma Breakdown of academic impact, for papers by Qiuzhi Cindy Cui Breakdown of academic impact, for papers by Marinella Roberti Breakdown of academic impact, for papers by Dayong Shi Breakdown of academic impact, for papers by Hongtao Xu Breakdown of academic impact, for papers by Peter L. Gutiérrez Breakdown of academic impact, for papers by Woo Hyun Park Breakdown of academic impact, for papers by Zhiguo Liu Breakdown of academic impact, for papers by Lisa K. Folkes
Rankless by CCL
2026